Literature DB >> 20537629

Fertility results and outcomes after pure laparoscopic management of advanced-stage serous borderline tumors of the ovary.

Aminata Kane1, Catherine Uzan, Sebastien Gouy, Patricia Pautier, Pierre Duvillard, Philippe Morice.   

Abstract

The outcomes of 18 patients treated with pure laparoscopic management (treated conservatively in 14 patients) of serous borderline ovarian tumors with peritoneal implants were reviewed. Eight patients relapsed (three with an invasive recurrence), but none of the patients without residual disease at the end of surgery, or invasive implants or disease with a micropapillary pattern relapsed under the form of invasive carcinoma.
Copyright © 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20537629     DOI: 10.1016/j.fertnstert.2010.04.045

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  4 in total

1.  A meta-analysis on the impact of platinum-based adjuvant treatment on the outcome of borderline ovarian tumors with invasive implants.

Authors:  Ines Vasconcelos; Jessica Olschewski; Ioana Braicu; Jalid Sehouli
Journal:  Oncologist       Date:  2015-01-19

2.  Outcomes of fertility-sparing surgery for stage II and III serous borderline ovarian tumors.

Authors:  Ziyang Lu; Bin Li; Chao Gu
Journal:  J Int Med Res       Date:  2019-08-21       Impact factor: 1.671

3.  Risk Factors for Recurrence of Borderline Ovarian Tumours after Conservative Surgery and Impact on Fertility: A Multicentre Study by the Francogyn Group.

Authors:  Adele Ozenne; Marion De Berti; Gilles Body; Xavier Carcopino; Olivier Graesslin; Yohan Kerbage; Cherif Akladios; Cyrille Huchon; Alexandre Bricou; Camille Mimoun; Emilie Raimond; Lobna Ouldamer
Journal:  J Clin Med       Date:  2022-06-23       Impact factor: 4.964

Review 4.  Borderline ovarian tumours: management in the era of fertility-sparing surgery.

Authors:  Mattia Maramai; Fabio Barra; Mario Valenzano Menada; Sara Stigliani; Melita Moioli; Sergio Costantini; Simone Ferrero
Journal:  Ecancermedicalscience       Date:  2020-05-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.